Chalmers, James

Professor

  • 4303 Citations
  • 35 h-Index
1983 …2022
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where James Chalmers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Bronchiectasis Medicine & Life Sciences
Pneumonia Medicine & Life Sciences
Chronic Obstructive Pulmonary Disease Medicine & Life Sciences
Anti-Bacterial Agents Medicine & Life Sciences
Lung Medicine & Life Sciences
Sputum Medicine & Life Sciences
Pseudomonas aeruginosa Medicine & Life Sciences
Mortality Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2022

Research Output 1983 2020

Cystic fibrosis lung disease and bronchiectasis

Chalmers, J. D., Jan 2020, In : The Lancet Respiratory Medicine. 8, 1, p. 12-14 3 p.

Research output: Contribution to journalComment/debate

4 Downloads (Pure)

A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial

Bradley, J. M., Anand, R., O'Neill, B., Ferguson, K., Clarke, M., Carroll, M., Chalmers, J., De Soyza, A., Duckers, J., Hill, A. T., Loebinger, M. R., Copeland, F., Gardner, E., Campbell, C., Agus, A., McGuire, A., Boyle, R., McKinney, F., Dickson, N., McAuley, D. F. & 1 others, Elborn, S., 19 Dec 2019, In : Trials. 20, 1, p. 1-10 10 p., 747.

Research output: Contribution to journalArticle

Open Access
File
Bronchiectasis
Cost-Benefit Analysis
Clinical Trials
Standard of Care
Sputum
3 Citations (Scopus)

Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis

Sibila, O., Laserna, E., Shoemark, A., Keir, H. R., Finch, S., Rodrigo-Troyano, A., Perea, L., Lonergan, M., Goeminne, P. C. & Chalmers, J. D., 1 Jul 2019, In : American Journal of Respiratory and Critical Care Medicine. 200, 1, p. 33-41 9 p.

Research output: Contribution to journalArticle

Bronchiectasis
Bacterial Load
Anti-Bacterial Agents
Aztreonam
Quality of Life
2 Citations (Scopus)
106 Downloads (Pure)

Antimicrobial peptides, disease severity and exacerbations in bronchiectasis

Sibila, O., Perea, L., Cantó, E., Shoemark, A., Cassidy, D., Smith, A. H., Suarez-cuartin, G., Rodrigo-troyano, A., Keir, H. R., Oriano, M., Ong, S., Vidal, S., Blasi, F., Aliberti, S. & Chalmers, J. D., Sep 2019, In : Thorax. 74, 9, p. 835-842 8 p.

Research output: Contribution to journalArticle

Open Access
File
Secretory Leukocyte Peptidase Inhibitor
Bronchiectasis
Disease Progression
Peptides
Sputum
2 Citations (Scopus)

A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation

Shoemark, A., Cant, E., Carreto, L., Smith, A., Oriano, M., Keir, H. R., Perea, L., Canto, E., Terranova, L., Vidal, S., Moffitt, K., Aliberti, S., Sibila, O. & Chalmers, J. D., 1 Jun 2019, In : European Respiratory Journal. 53, 6, 1900303.

Research output: Contribution to journalArticle

Point-of-Care Systems
Leukocyte Elastase
Bronchiectasis
Sputum
Infection

Press / Media

Young Scientist Award for Dundee medical student

James D. Chalmers

19/09/1318/10/13

2 items of Media coverage

Press/Media: Research